Pleasant Surprises
April 15, 2010
One notable aspect of media coverage of clinical trials is the ready acceptance of the cost of a particular clinical research program. In every notable publication, as far as we can tell, the cost of a trial or a research program is confidently said to be so many tens or hundreds of millions of dollars. The amount…more...
Excellence, Not Hugeness
March 24, 2009
One man's middle of nowhere is another man's perfectly situated. That's the way Paul Bishop and Lyle Camblos see Staunton, the small Virginia town that's home to their contract research organization (CRO), Atlantic Research Group (ARG).
“It's equidistant from Rockville and RTP,” says Camblos, speaking of the myriad biotech companies along the I-270 corridor in Rockville, Md.,…more...
Beyond Spreadsheets
March 19, 2009
Even in 2009, in a context of clinical trials, "management" can mean just about anything. It may mean ... Karen, three cubicles away. Or a 5-year-old spreadsheet. Or a system that cost millions but sits unused. As a result, it's fair to say that clinical trial management systems (CTMS) do not enjoy a reputation for easy implementation,…more...
Reality-Based Budgeting
August 05, 2008
Want to get depressed? The Tufts Center For the Study of Drug Development has analyzed the length of clinical trials during two time periods: 1999-2002 and 2003-2006. The median number of days from first to last patient visit has doubled, to 598. Nineteen months.
Can anyone think of any industry that takes twice as long to do…more...
Veeda Picks ClinPhone CTMS
A cancer-oriented CRO says ease of use and the ability to tailor payments were key factors in its choice.
No Laptop Required
IT departments like the new version of its Impact software, which now runs on a thumb drive.
Fewer Features & Faster Setup
ACS talks about a new product. The company is betting the combination of EDC and CTMS will appeal to biotech firms and contract research organizations.
Expert Author
Bayer’s Rob Musterer discusses why current clinical trial management systems aren’t serving the industry.
A Tale Of Two CROs
With impressive numbers, Pfizer’s Mike Collins talked about how the company is streamlining its clinical trial process.
Laminated Cards For Sites
In the third part of our series, a softer approach to win the hearts of clinician-investigators.
Master Service Agreements
In the second segment of our series on investigator relationship management, Lilly discusses plans to zero in on high-performing sites.
